LCIF's Core 4 Diabetes program enables Lions to realize a variety of initiatives to prevent and reduce the impact of diabetes as a public health concern. This program awards multi-year grants (up to US$75,000 for Lions single districts or up to US$200,000 for multiple districts) for large-scale Lions efforts to support the expansion and enhancement of diabetes education, prevention and treatment programs.
Typical items supported include the printing and translation of awareness materials, development of self-management courses for diabetics, diabetes and diabetic retinopathy testing equipment, human resource trainings, community awareness and promotion.
In the last twelve years, LCIF has provided US$1.5 million to 19 Core 4 Diabetes projects in the United States, Australia, Denmark, Finland, Korea and Turkey.
Download the Diabetes Grant Criteria/Application to apply for a grant.
LCIF also supports diabetic retinopathy programs through its SightFirst Program.
Diabetes is a disease in which the body either does not produce or does not properly use insulin. Diabetes can lead to serious health complications and premature death. According to the World Health Organization (WHO), this disease currently affects 346 million people worldwide, and cases will continue to steadily increase. The largest increases in diabetes prevalence will take place in developing countries. In 2011 in the United States, 25.8 million people or 8.3 percent of the population were affected by diabetes, according to the Centers for Disease Control and Prevention.
Over time, diabetes can damage the heart, blood vessels, eyes, kidneys and nerves, and the overall risk of dying among people with diabetes is at least double the risk of their peers without diabetes, according to the WHO. Education, prevention and treatment programs are important tools to help people with this disease.